Corinne Johnson
Stock Analyst at Goldman Sachs
(1.60)
# 3,206
Out of 4,753 analysts
7
Total ratings
66.67%
Success rate
-0.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $33.34 | +76.96% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $28.20 | +34.78% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $29.95 | +66.94% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $20.91 | +139.12% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $33.34
Upside: +76.96%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $28.20
Upside: +34.78%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $29.95
Upside: +66.94%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $20.91
Upside: +139.12%